10X Genomics Inc (TXG)

$18.31 +0.96 (5.53%)
Market Cap 2.31B
Revenue (ttm) 642.82M
Net Income (ttm) -43.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.77%
Debt to Equity Ratio 0.00
Volume 1,019,323
Avg Vol 2,704,820
Day's Range N/A - N/A
Shares Out 127.75M
Stochastic %K 26%
Beta 2.20
Analysts Sell
Price Target $20.14

Company Profile

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and singl...

Industry: Health Information Services
Sector: Healthcare
Phone: 925 401 7300
Address:
6230 Stoneridge Mall Road, Pleasanton, United States
mkultra
mkultra Mar. 18 at 11:23 PM
$TXG NIH funding turned back on. TXG is gonna absolutely rip this year
0 · Reply
topstockalerts
topstockalerts Mar. 17 at 5:18 PM
Shares of Bruker Corporation and 10x Genomics fell after Satya Nadella highlighted GigaTIME, an AI model developed by Microsoft, Providence Health, and the University of Washington that can predict multiplex immunofluorescence results from H&E pathology slides. The selloff reflected concerns that AI could reduce demand for spatial proteomics, but Wolfe Research argued the reaction was overdone, noting these tools are not yet widely used in clinical settings and the underlying study was published months ago in Cell. GigaTIME uses multimodal AI trained on 40 million cells and tested across 14,000+ patients, analyzing 21 protein markers including PD-L1. However, Wolfe said this marker set is relatively limited compared to traditional methods, suggesting the technology remains early-stage rather than a near-term replacement. $BRKR $TXG
1 · Reply
medguy
medguy Mar. 17 at 5:44 AM
Looking for bounce $TXG $VIA
0 · Reply
financials_please
financials_please Mar. 16 at 7:35 PM
$TXG based on past history, Cathy dumping is a glowing endorsement here 😂
1 · Reply
Guadangia
Guadangia Mar. 16 at 6:53 PM
$TXG I bought a few from Cathie's today. AFAIK Ark has around 11 million shares, and she sold how many, 750k, 1 million? Still has 10M shares... And anyways that's not the important thing. The chart speaks itself. I thought the right shoulder would take a few more sessions to develop (green box), but it seems they are in a rush. Very optimistic on this one (targets in blue box).
0 · Reply
Eddyg987
Eddyg987 Mar. 16 at 3:48 PM
$TXG cathy has decided to dump her shares
3 · Reply
buyitall888
buyitall888 Mar. 16 at 2:45 PM
$TXG omg why's it tanking huge rn
0 · Reply
dark_gamma
dark_gamma Mar. 11 at 10:37 PM
$USO OPTIONS LEVELS UPDATE Current Date: 2026-03-11 Key Levels to Watch: ✅ Call Wall: $110.00 - A significant resistance level ❌ Put Wall: $108.00 - A crucial support level ⚡ Gamma Flip: $109.39 - A level of increased sensitivity to price movements Whale Activity: ~ Dark Gamma: $106.40 - A whale's position indicating potential market direction • Whale 1: $105.92 • Whale 2: $TXG • Whale 3: $106.14 • Whale 4: $TXG • Whale 5: $105.70 - Various whale positions revealing market sentiment Volatility Ranges: ⬆ Upper: 1σ $116.12 | 2σ $124.19 - Indicative of potential price increases ⬇ Lower: 1σ $99.98 | 2σ $91.91 - Indicative of potential price decreases Daily Level Updates: Check back regularly for updated market information. Disclaimer: This information is for educational purposes only and should not be considered as investment advice.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 2:45 AM
$TXG RSI: 68.92, MACD: 0.7335 Vol: 1.71, MA20: 19.60, MA50: 19.46 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:01 PM
$TXG 3/2 Stifel raises target price to $25 from $20
0 · Reply
Latest News on TXG
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

Mar 17, 2026, 8:00 AM EDT - 2 days ago

PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

Feb 19, 2026, 4:05 PM EST - 27 days ago

10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

Torex Gold Resources Inc. (TXG:CA) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 11:45 AM EST - 4 weeks ago

Torex Gold Resources Inc. (TXG:CA) Q4 2025 Earnings Call Transcript

10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript

Feb 14, 2026, 12:27 AM EST - 4 weeks ago

10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026

Feb 12, 2026, 4:05 PM EST - 4 weeks ago

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

Feb 4, 2026, 9:00 AM EST - 6 weeks ago

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Jan 22, 2026, 4:05 PM EST - 7 weeks ago

10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 2:56 PM EST - 2 months ago

10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Jan 12, 2026, 9:11 AM EST - 2 months ago

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Jan 12, 2026, 9:10 AM EST - 2 months ago

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Jan 12, 2026, 9:00 AM EST - 2 months ago

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Jan 11, 2026, 12:00 PM EST - 2 months ago

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Jan 7, 2026, 7:05 AM EST - 2 months ago

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CDNA

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:05 PM EST - 2 months ago

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium

Nov 18, 2025, 9:00 AM EST - 4 months ago

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025

Nov 11, 2025, 4:05 PM EST - 4 months ago

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025

10x Genomics, Inc. (TXG) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 10:56 PM EST - 4 months ago

10x Genomics, Inc. (TXG) Q3 2025 Earnings Call Transcript

10x Genomics Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 4 months ago

10x Genomics Reports Third Quarter 2025 Financial Results

Torex Gold Resources Inc. (TXG:CA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:56 AM EST - 4 months ago

Torex Gold Resources Inc. (TXG:CA) Q3 2025 Earnings Call Transcript

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

Oct 29, 2025, 9:00 AM EDT - 5 months ago

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences

Oct 20, 2025, 12:30 PM EDT - 5 months ago

10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 9, 2025, 4:05 PM EDT - 5 months ago

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

Oct 9, 2025, 8:00 AM EDT - 5 months ago

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

10x Genomics, Inc. (TXG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 2:14 PM EDT - 6 months ago

10x Genomics, Inc. (TXG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

Sep 9, 2025, 9:00 AM EDT - 6 months ago

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 4:05 PM EDT - 7 months ago

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis

Aug 19, 2025, 9:00 AM EDT - 7 months ago

10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis

10x Genomics, Inc. (TXG) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 4:13 AM EDT - 7 months ago

10x Genomics, Inc. (TXG) Q2 2025 Earnings Call Transcript

10x Genomics Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 7 months ago

10x Genomics Reports Second Quarter 2025 Financial Results

10x Genomics to Acquire Scale Biosciences

Aug 7, 2025, 4:04 PM EDT - 7 months ago

10x Genomics to Acquire Scale Biosciences

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

Jul 17, 2025, 9:00 AM EDT - 8 months ago

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 10, 2025, 4:05 PM EDT - 8 months ago

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

May 14, 2025, 4:05 PM EDT - 11 months ago

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:34 PM EDT - 11 months ago

10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript

10x Genomics Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 11 months ago

10x Genomics Reports First Quarter 2025 Financial Results

10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference

Apr 30, 2025, 4:05 PM EDT - 11 months ago

10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference

Vizgen Announces End of Litigation with 10x Genomics and Harvard University

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Vizgen Announces End of Litigation with 10x Genomics and Harvard University

10x Genomics: Lower Cost Innovation May Drive A Rebound

Mar 20, 2025, 3:12 AM EDT - 1 year ago

10x Genomics: Lower Cost Innovation May Drive A Rebound

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

Mar 3, 2025, 4:05 PM EST - 1 year ago

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

Feb 23, 2025, 11:30 AM EST - 1 year ago

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

Feb 18, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties

Feb 13, 2025, 3:10 PM EST - 1 year ago

Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties

10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 8:53 PM EST - 1 year ago

10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript

Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 1 year ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN PACB

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

Feb 12, 2025, 4:05 PM EST - 1 year ago

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Feb 6, 2025, 8:30 AM EST - 1 year ago

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products

Feb 4, 2025, 8:59 AM EST - 1 year ago

Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products

Spatial Omics Research Report 2023-2034: Market to reach $1.09 Billion - 10x Genomics Enhances Spatial OMICS with New Visium Spatial Gene Expression for FFPE

Jan 31, 2025, 6:34 AM EST - 1 year ago

Spatial Omics Research Report 2023-2034: Market to reach $1.09 Billion - 10x Genomics Enhances Spatial OMICS with New Visium Spatial Gene Expression for FFPE

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

Jan 28, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

mkultra
mkultra Mar. 18 at 11:23 PM
$TXG NIH funding turned back on. TXG is gonna absolutely rip this year
0 · Reply
topstockalerts
topstockalerts Mar. 17 at 5:18 PM
Shares of Bruker Corporation and 10x Genomics fell after Satya Nadella highlighted GigaTIME, an AI model developed by Microsoft, Providence Health, and the University of Washington that can predict multiplex immunofluorescence results from H&E pathology slides. The selloff reflected concerns that AI could reduce demand for spatial proteomics, but Wolfe Research argued the reaction was overdone, noting these tools are not yet widely used in clinical settings and the underlying study was published months ago in Cell. GigaTIME uses multimodal AI trained on 40 million cells and tested across 14,000+ patients, analyzing 21 protein markers including PD-L1. However, Wolfe said this marker set is relatively limited compared to traditional methods, suggesting the technology remains early-stage rather than a near-term replacement. $BRKR $TXG
1 · Reply
medguy
medguy Mar. 17 at 5:44 AM
Looking for bounce $TXG $VIA
0 · Reply
financials_please
financials_please Mar. 16 at 7:35 PM
$TXG based on past history, Cathy dumping is a glowing endorsement here 😂
1 · Reply
Guadangia
Guadangia Mar. 16 at 6:53 PM
$TXG I bought a few from Cathie's today. AFAIK Ark has around 11 million shares, and she sold how many, 750k, 1 million? Still has 10M shares... And anyways that's not the important thing. The chart speaks itself. I thought the right shoulder would take a few more sessions to develop (green box), but it seems they are in a rush. Very optimistic on this one (targets in blue box).
0 · Reply
Eddyg987
Eddyg987 Mar. 16 at 3:48 PM
$TXG cathy has decided to dump her shares
3 · Reply
buyitall888
buyitall888 Mar. 16 at 2:45 PM
$TXG omg why's it tanking huge rn
0 · Reply
dark_gamma
dark_gamma Mar. 11 at 10:37 PM
$USO OPTIONS LEVELS UPDATE Current Date: 2026-03-11 Key Levels to Watch: ✅ Call Wall: $110.00 - A significant resistance level ❌ Put Wall: $108.00 - A crucial support level ⚡ Gamma Flip: $109.39 - A level of increased sensitivity to price movements Whale Activity: ~ Dark Gamma: $106.40 - A whale's position indicating potential market direction • Whale 1: $105.92 • Whale 2: $TXG • Whale 3: $106.14 • Whale 4: $TXG • Whale 5: $105.70 - Various whale positions revealing market sentiment Volatility Ranges: ⬆ Upper: 1σ $116.12 | 2σ $124.19 - Indicative of potential price increases ⬇ Lower: 1σ $99.98 | 2σ $91.91 - Indicative of potential price decreases Daily Level Updates: Check back regularly for updated market information. Disclaimer: This information is for educational purposes only and should not be considered as investment advice.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 2:45 AM
$TXG RSI: 68.92, MACD: 0.7335 Vol: 1.71, MA20: 19.60, MA50: 19.46 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:01 PM
$TXG 3/2 Stifel raises target price to $25 from $20
0 · Reply
erevnon
erevnon Mar. 2 at 3:54 PM
Stifel maintains 10x Genomics $TXG at Buy and raises the price target from $20 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
NorthStarStats
NorthStarStats Feb. 27 at 12:54 PM
For anyone following along, I developed a Python-based statistical scanner to identify stocks with near-term institutional accumulation and upward price momentum. Tricky market guys. Stay Safe. Today's stocks to look at: $CZR Score: 95.00, $TGTX Score: 93.00, $TXG Score: 85.00, $AVB Score: 77.00, $DELL Score: 73.00
0 · Reply
Bates333
Bates333 Feb. 26 at 9:03 PM
$TXG nice
0 · Reply
WAJeff
WAJeff Feb. 26 at 8:59 PM
$TXG Sold at a breakeven
0 · Reply
sdodier
sdodier Feb. 26 at 8:44 PM
$TXG Look's good to me .... any reason for the up trend ?
0 · Reply
WOLFSTREET
WOLFSTREET Feb. 26 at 8:26 PM
$TXG $F Mustangs are toooooo sweet!
1 · Reply
WOLFSTREET
WOLFSTREET Feb. 26 at 8:21 PM
$TXG 8 Months 65%++ @WorkingGal I have covered this one along the way, going to smoke the tires today, a bit.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 21 at 6:24 PM
$TXG Current Stock Price: $18.88 Contracts to trade: $20.0 TXG Mar 20 2026 Call Entry: $1.00 Exit: $1.71 ROI: 71% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Bates333
Bates333 Feb. 13 at 8:21 PM
$TXG goodness gracious
0 · Reply
RazorbackAJ
RazorbackAJ Feb. 13 at 2:36 PM
$TXG Good start - expecting more gains! Follow for such precise calls with actual stop loss levels.
0 · Reply
RazorbackAJ
RazorbackAJ Feb. 12 at 10:36 PM
$TXG Amazing reversal on decent earnings after hours - going long here with current trailing stop at $15.50.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 12 at 9:15 PM
$TXG Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.13 up 67.50% YoY • Reported revenue of $166.03M up 0.61% YoY • 10x Genomics expects full year 2026 revenue to be in the range of $600M to $625M. Excluding non-recurring patent litigation settlements, this represents 0% to 4% growth over full year 2025.
0 · Reply